吉林敖东 (000623)

Jilin Aodong Pharmaceutical Group Co., Ltd.

ASZ

Tags

MSCI Mid Cap IndexCSI Share Buyback IndexLow Price-to-Book RatioLow Price-to-Earnings RatioVenture Capital ConceptBroker Heavy PositionsInvestments in Financial InstitutionsFace Mask ProtectionGuozheng Value IndexInfant and Child ConceptSmall Cap ValueHelicobacter PyloriBelow Net Asset ValueHigh-Performing StocksShenzhen ConnectSZSE 300 IndexSZSE Value IndexCSFC HoldingsPharma & BiotechChinese Med. IISZSE Medicine Equal Weight IndexSZSE Clock IndexPharmaceutical IndexSina 100 IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexCSI 800 Dividend Low Volatility IndexSZSE Emerging Industries IndexSZSE 1000 IndexSZSE 300 Return IndexSZSE Component Index ReturnCNI 1000 IndexOrient Securities Value IndexCSI 500 Value Stable IndexInfluenza/MaskNew Virus PreventionConvertible Bond IssuersFTSE Russell ConceptHuijin ConceptInsurance Heavy HoldingsStocks Below Book ValuePublic Health IndexSZSE Selected IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexA500 Dividend Low Volatility IndexSZSE Component Pharmaceutical IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexPrivate Enterprise Development IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightHigh Dividend Yield Strategy IndexCSI 700 IndexMid-small Cap IndexSZSE Fundamental 200 IndexCSI 500 IndexCSI 500 IndexSmall-cap Low Volatility IndexCSI 500 Growth Innovation IndexSZSE 200 Return IndexSZSE 200 IndexCICC 300 IndexCSI 500 Smart Low Volatility IndexCR New Momentum IndexCSI 1000 Value IndexSZSE 500 IndexFundamental 600 IndexCSI 500 ESG IndexJilin

K-Line Chart

No K-line data available

Company NameJilin Aodong Pharmaceutical Group Co., Ltd.
Listing Date1996-10-28
Issue Price7.2RMB
Registered Capital119589.538710k RMB
Legal RepresentativeLi Xiulin
Registered AddressNo. 2158, Aodong Street, Dunhua City, Jilin Province
IndustryTraditional Chinese Medicine II
Main BusinessPharmaceutical Industry, Pharmaceutical Commerce, Pharmaceutical Research and Development; Planting and Breeding, Commerce (excluding items under special state control and monopoly), Machinery Repair, Warehousing; Import of raw and auxiliary materials, machinery equipment, instruments and meters, spare parts required for the company's production and research (excluding the 12 import items subject to state-approved company operation).
Company ProfileThe predecessor of Jilin Aodong Pharmaceutical Group Co., Ltd. was the state-owned Yanbian Dunhua Deer Farm established in 1957. The Aodong Pharmaceutical Factory was established in 1981. In March 1993, it was restructured and approved by the Provincial Economic Restructuring Commission to become Jilin Aodong Pharmaceutical Group Co., Ltd. It was listed on the Shenzhen Stock Exchange on October 28, 1996. Currently, the company controls 7 specialized pharmaceutical subsidiaries engaged in modern traditional Chinese medicine, biochemical drugs, and phytochemical drugs; 4 pharmaceutical sales subsidiaries; 5 pharmaceutical supporting subsidiaries; 2 high-end health product companies; 1 highway construction and toll company; and 1 Aodong International (Hong Kong) Industrial Co., Ltd.

Stock Details

1. Key Indicators

  • Total Shares(W): 119589.54
  • Circulating A-Shares(W): 119102.34
  • Earnings Per Share(RMB): 1.9262
  • Net Assets Per Share(RMB): 25.5610
  • Operating Revenue(W RMB): 164031.45
  • Total Profit(W RMB): 234370.02
  • Net Profit Attributable to Parent(W RMB): 226049.64
  • Net Profit Growth Rate(%): 81.70
  • Weighted Return on Equity(%): 7.5600
  • Operating Cash Flow Per Share(RMB): 0.1350
  • Undistributed Profit Per Share(RMB): 17.9437
  • Capital Reserve Per Share(RMB): 4.0952

2. Main Business

The main business covers:

  • Research, manufacturing and sales of traditional Chinese medicine
  • Research, manufacturing and sales of chemical drugs

3. Company Basic Information

  • Company Name: Jilin Aodong Pharmaceutical Group Co., Ltd.
  • Listing Date: 1996-10-28
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 2158, Aodong Street, Dunhua City, Jilin Province, China
  • Website: www.jlaod.com
  • Company Profile: The company's predecessor was Yanbian State-owned Dunhua Deer Farm. In February 1992, it was jointly established by Yanbian Aodong Group Company and two other companies. Initially, its net assets and cash investment were converted into 36.658 million state shares, 10 million promoter shares, 23.742 million private placement legal person shares, and 17.6 million employee shares. In August 1994, the total shares were adjusted to 58 million shares; after the first online pricing issuance from October 8 to 16, 1996, the total shares at listing were 71.6 million shares; 4.4 million internal employee shares were listed for trading together with its public shares on October 28, 1996.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Dunhua Jincheng Industrial Co., Ltd. General Legal Person 32708.07 27.46
2 GF Securities Co., Ltd. Securities Firm 4322.05 3.63
3 Jilin Aodong Pharmaceutical Group Co., Ltd. - Phase 1 Employee Stock Ownership Plan General Legal Person 2550.27 2.14
4 CSI 500 Exchange Traded Open-end Index Securities Investment Fund Fund 1393.00 1.17
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1181.75 0.99
6 Guangdong Dehui Investment Management Co., Ltd. - Dehui Global Select Private Securities Investment Fund Private Securities Investment Fund 797.51 0.67
7 Yanbian State-owned Assets Management Corporation General Legal Person 607.99 0.51
8 ChinaAMC CSI Traditional Chinese Medicine Exchange Traded Open-end Index Securities Investment Fund Fund 597.74 0.50
9 Penghua CSI Traditional Chinese Medicine Exchange Traded Open-end Index Securities Investment Fund Fund 223.70 0.19
10 China Merchants CSI 500 Equal Weight Index Enhanced Securities Investment Fund Class A Fund 50.20 0.04

5. Concept Sectors

  • Venture Capital Concept
  • Infant and Child Concept
  • Rural Revitalization
  • Industrial Internet
  • Internet Celebrity Economy
  • Mask Protection
  • Helicobacter Pylori
  • Hepatitis Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Financial Shareholding
  • Low Price-to-Book Ratio
  • Low Price-to-Earnings Ratio
  • High-Performance Stocks
  • Securities Firm Heavy Holdings
  • Below Net Asset Value
  • MSCI Mid Cap
  • SZSE Value
  • SZSE Component Index
  • Small Cap Value
  • SZSE 300
  • CNI Value
  • CSI Buyback

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information